Stock Markets Analysis & Opinion

From a broad perspective, the story surrounding TLRY stock is delayed, not broken But subpar execution has been as big a problem as slow regulators Long term, the stock can still work out, but at the...

Bernstein's semiconductor analyst Stacy Rasgon downgraded NVIDIA's (NASDAQ:NVDA) price target to $180 from $210.The US government instructed the chipmaker to stop selling chips to China and Russia, as...

By now you’ve likely heard that September is the worst month for stocks. It’s all over the media! But September is also a great time to buy a unique type of dividend fund that cashes in...

Stocks finished the day higher yesterday in a repeat of the Jackson Hole episode. Stocks rallied sharply on Aug. 25, the day before Powell. Stocks rallied sharply yesterday, a day before Powell. The...

At this point, the chorus has become universal. “We’re oversold! The McClellan Oscillator has never been this low! We’ve been down seven days in a row!” And so on. One of the...

The Biden administration declared an intermediate target in August 2021 that 50% of all new automobiles would be electrified by 2030.This transition to lithium-ion battery power will potentially guard...

Everyone is an expert with the benefit of hindsight. It is easy to give a successful trade as an example of how things should be done. In reality, however, trading is messy and uncertain. Even the...

G-III Apparel Group (NASDAQ:GIII) is a well-established company with solid results for the Q2 period, but it may also be a value trap. The company’s brands are not as strong as others in the...

Solar stocks have been on fire lately (pun intended). The sector is getting a boost from the Biden administration, which has announced a broad goal for 45% of the nation’s energy supply to come...

Zoom is finding it hard to fuel growth in an environment where people are returning to their normal routines The company's bet on enterprise customers may not pay off soon amid stiff competition Until...

2022 has been one long, painful lesson for investors and traders Learning from the best is one way to get through it We use InvestingPro+ to find ideas from the world’s best...

MRNA is an exceptionally difficult stock to value, given enormous uncertainty surrounding its COVID-19 vaccine and other drugs in its pipeline But there is a case that an enterprise value still over...

After a 31.4% slump year to date and a 33.1% slide from its Nov. 4, 2021 record close, is Tesla (NASDAQ:TSLA) a bargain?Tesla does have a lot going for it. The company showed resilience to challenges...

One of my members wrote this headline in our trading room when the market dropped after the recent Fed meeting. And, the reason he did so was to illustrate just how ridiculous most of the...